Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

The next frontier – the German outpatient sector

The outpatient sector in Europe, long fragmented into millions of providers, is the new frontier for consolidation. And no market is bigger than Germany where medical offices accounted for €51.5bn of expenditure in 2016 and statutory insurers spent €13.7bn alone on dentistry. Many investors and entrepreneurs have the sector in their sights.

“Very profitable” Ober Scharrer heading for a sale?

Rumour has it that German ophthalmology chain Ober Scharrer will be sold in the winter. Of course, its CEO Sibylle Stauch-Eckmann couldn’t possibly comment. Nonetheless, she tells us the group now has 5% of the country’s rapidly consolidating eye-care market and a strong pipeline offering further growth.

Capio buys Norwegian ophthalmology chain

Listed Swedish healthcare provider Capio has bought its third ophthalmology operator in a year, acquiring Norwegian company Orbita. We speak to Capio about the deal and look at how private hospitals are moving from inpatient to outpatient.

“We can meet the needs of the baby boom generation with today’s medical capacity”

That is a very bold statement indeed. But Prof Richard Boucherie at the Centre for Healthcare Operations Improvement and Research (CHOIR) of the University of Twente in the Netherlands, reckons it is true. For the past 15 years CHOIR has been helping Dutch hospitals, labs and homecare groups to increase their efficiency through mathematical modelling using operations research methods including queueing theory, optimisation and computer simulation. We interview him on how such an approach can make massive efficiency gains.

Capio enters the German ophthalmology market

Pan-European healthcare provider Capio has bought German ophthalmology clinic Augenklinik Universitätsallee in Bremen - its first opthalmology acquisition in the country. Henrik Brehmer, SVP Group Communication at Capio, talks to us about the deal. Is Capio looking to buy more in this market?

Dr Agarwal plans further African expansion

The Indian eye care chain Dr Agarwal won’t cure its itchy feet, and after opening in two new African countries this summer has taken its total investment on the continent to US$15m. Managing director S. Rajagopalan told Healthcare Nova at the African Health Business Symposium in Kenya how it makes money on a continent where it's now reached one million patients.

Find Us